Hannah Mamuszka
Direktor/Vorstandsmitglied bei BIONANO GENOMICS, INC.
Vermögen: 4 993 $ am 30.04.2024
Profil
Hannah Mamuszka is the founder of Alva10, Inc. which was founded in 2016, where she holds the title of Chief Executive Officer.
She is currently an Independent Director at Bionano Genomics, Inc. since 2020.
Ms. Mamuszka's former positions include Director-Strategic Business Development at Asuragen, Inc., Director-Scientific & Pharmaceutical Alliances at Oncotech, Inc. from 2005 to 2012, Principal at Organogenesis, Inc. and Millennium Pharmaceuticals, Inc. She was also the VP-Business Development & Clinical Strategy at Exosome Diagnostics, Inc. from 2010 to 2015.
Ms. Mamuszka's education includes a graduate degree from Harvard University and an undergraduate degree from the University of Maryland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0,01% | 15.04.2024 | 6 579 ( 0,01% ) | 4 993 $ | 30.04.2024 |
Aktive Positionen von Hannah Mamuszka
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONANO GENOMICS, INC. | Direktor/Vorstandsmitglied | 04.05.2020 |
| Alva10, Inc. | Vorstandsvorsitzender | 01.03.2016 |
Ehemalige bekannte Positionen von Hannah Mamuszka
| Unternehmen | Position | Ende |
|---|---|---|
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.06.2015 |
Oncotech, Inc.
 Oncotech, Inc. Miscellaneous Commercial ServicesCommercial Services Oncotech, Inc. provides molecular oncology testing services. The firm's services improve the survival and quality of life of cancer patients through its molecular oncology testing services. Oncotech provides its testing services to hospitals in the US. The company was founded in 1985 and is headquartered in Tustin, CA. | Technik-/Wissenschafts-/F&E-Leiter | 29.08.2012 |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Hannah Mamuszka
| University of Maryland | Undergraduate Degree |
| Harvard University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Oncotech, Inc.
Oncotech, Inc. Miscellaneous Commercial ServicesCommercial Services Oncotech, Inc. provides molecular oncology testing services. The firm's services improve the survival and quality of life of cancer patients through its molecular oncology testing services. Oncotech provides its testing services to hospitals in the US. The company was founded in 1985 and is headquartered in Tustin, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
| Alva10, Inc. |
